Suppr超能文献

[冠状动脉内给药后依诺昔酮对血流动力学、心肌灌注及局部室壁运动的急性影响]

[Acute effects of enoximone after intracoronary administration on hemodynamics, myocardial perfusion and regional wall motion].

作者信息

Mitrovic V, Strasser R, Berwing K, Thormann J, Schlepper M

机构信息

Kerckhoff-Klinik, Bad Nauheim.

出版信息

Z Kardiol. 1996 Nov;85(11):856-67.

PMID:9064948
Abstract

The influence of intracoronary enoximone at a dose of 0.075 mg/ kg/10 min on global and regional wall motion and myocardial perfusion (Group I, n = 10) as well as on diastolic LV function (Group II, n = 8) during pacing-induced ischemia was investigated in 18 patients with significant LAD stenoses. The hemodynamic parameters were determined by left heart catheterization, the systolic and diastolic left ventricular function by echocardiography including Doppler technique, and myocardial perfusion analysis was done after intracoronary application of contrast medium. Enoximone did not change either heart rate (79 +/- 9 vs 80 +/- 9 min-1) or blood pressure (LVSP: 159 +/- 7 vs 162 +/- 5 mm Hg) at rest. In the postpacing ischemic period after enoximone, LVEDP fell from a mean of 28.9 to 18.4 mm Hg (p < 0.001), dp/dtmax increased from 1050 to 1369 mm Hg/s (p < 0.001) and regional EF from 47% to 58% (p < 0.01), while global EF remained unchanged (45% vs 47%). ST-segment depression was reduced significantly from 2.3 to 1.5 mm (p < 0.01). Enoximone induced an increase in myocardial perfusion by 129% (p < 0.001) in the stenosis-dependent myocardial areas with shortening of the wash-out half-life time of the echo contrast medium from a mean of 14 s to 5 s (p < 0.001). The isovolumetric relaxation was shortened by 13% (p < 0.05), the E wave by 5%, and dp/dtmin increased by 17% (p < 0.01). In summary, intracoronary application of enoximone led to an improvement in both systolic and diastolic LV function without concomitant peripheral effect due to regression of myocardial ischemia.

摘要

在18例患有严重左前降支狭窄的患者中,研究了剂量为0.075mg/kg/10min的冠状动脉内依诺昔酮在起搏诱导缺血期间对整体和局部室壁运动及心肌灌注(I组,n = 10)以及左心室舒张功能(II组,n = 8)的影响。通过左心导管检查测定血流动力学参数,采用包括多普勒技术的超声心动图测定左心室收缩和舒张功能,并在冠状动脉内注入造影剂后进行心肌灌注分析。依诺昔酮在静息时既不改变心率(79±9次/分钟 vs 80±9次/分钟)也不改变血压(左心室收缩压:159±7mmHg vs 162±5mmHg)。在依诺昔酮后的起搏后缺血期,左心室舒张末期压力从平均28.9mmHg降至18.4mmHg(p<0.001),dp/dtmax从1050mmHg/s增加至1369mmHg/s(p<0.001),局部射血分数从47%增加至58%(p<0.01),而整体射血分数保持不变(45% vs 47%)。ST段压低从2.3mm显著降低至1.5mm(p<0.01)。依诺昔酮使狭窄相关心肌区域的心肌灌注增加129%(p<0.001),同时回声造影剂的洗脱半衰期从平均14秒缩短至5秒(p<0.001)。等容舒张期缩短13%(p<0.05),E波缩短5%,dp/dtmin增加17%(p<0.01)。总之,冠状动脉内应用依诺昔酮可改善左心室收缩和舒张功能,且由于心肌缺血的消退而无伴随的外周效应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验